Close
Research & Publications
Search result for "Solr search content"
Search Result for ""
Cancer Treatment
Transarterial Chemoembolization (TACE)
Transarterial chemoembolization (TACE) is a minimally invasive treatment used for liver cancer. It is an alternative to surgery that directs a high dose of chemotherapy straight to the tumor.
Cancer Treatment
Thermal Ablation
Thermal ablation is a minimally invasive treatment used for many health conditions, including cancers of the bone, kidney, liver and lung. It can benefit people with early stage, small tumors or those awaiting liver transplant. Thermal ablation uses extreme heat or cold to destroy cancer cells.
Cancer Treatment
Radioactive Iodine (RAI) Therapy
Radioactive iodine (RAI) therapy is a treatment for thyroid conditions such as Graves’ disease and some types of thyroid cancer. It treats cancerous or other unhealthy cells that remain in the body after surgery.
Cancer Treatment
Theranostics
Nuclear radiologists at UT Health San Antonio have been at the forefront of clinical breakthroughs in theranostic imaging and therapy for years.
Cancer Treatment
Transarterial radioembolization
Transarterial radioembolization (TARE) is a minimally invasive radiation treatment for liver cancer and other cancers that have spread (metastasized) to the liver. It is also called Y-90, which is short for yttrium-90, a radioactive substance.
provider
Alexander Papanastassiou, MD Neurosurgery
Story
New book provides big recommendations from the Advancing the Science of Cancer in Latinos Conference
Research findings, strategies target the leading cause of Latino death With cancer still rising in the U.S. Latino population, leaders at The University of Texas Health Science Center at San Antonio (UT Health San Antonio) and national cancer experts have published an online book with innovative recommendations to reduce Latino cancer. The book, “Advancing the […]
Story
You are the essential piece: Building the future of health through clinical trials
The process is often imagined as a single, sudden 'aha!' moment. It’s much more like building a massive, intricate structure—a colossal puzzle that represents all medical knowledge. Every time a treatment is approved, a new piece of the puzzle clicks into place.
Story
Cracking cancer’s code: New research identifies novel drug target for acute myeloid leukemia treatment
Despite advances in cancer treatment in recent years, five-year survival rates for acute myeloid leukemia (AML) remain low at just 30% on average, according to the National Cancer Institute. Factors in the development of AML are diverse with many different drivers. A longtime goal for scientists in this field is finding a single drug that can treat all types of AML.